Entering text into the input field will update the search result below

Cytokinetics misses by $0.35, misses on revenue

  • Cytokinetics (NASDAQ:CYTK): Q1 EPS of -$0.62 misses by $0.35.
  • Revenue of $4.15M (-50.7% Y/Y) misses by $16.66M.
  • Press Release

Recommended For You

More Trending News

About CYTK Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CYTK--
Cytokinetics, Incorporated